Clinical Trial Update: A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 study of LY3108743 in healthy participants and individuals with Type 2 diabetes has completed, indicating initial safety and pharmacokinetic assessmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3108743

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED